InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,717.20
(
0.20%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.82
(
0.52%
)
Bitcoin
62,799.09
(
2.20%
)
Post# of 6315
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Closewatcher

Send PM Follow Ignore
Followers 1
Posts 150
Boards Moderated 0
Alias Born 11/17/2016

Closewatcher

Re: None

Monday, 08/07/2017 7:46:15 AM

Monday, August 07, 2017 7:46:15 AM

Post# of 6315
ZYNE unfortunately came up short in their Phase 2 trial for ZYN002...bad for medical community, hopefully get a boost here.

We've been chattering about how NEMUS science has been better for years from the get-go, so maybe $$$ will flow into here.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SKYE News
More SKYE News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!